Disclosed are methods for detecting multidrug resistance in neoplastic or
damaged cells or multidrug resistant (MDR) neoplastic or damaged cells by
detecting an increase in the cell surface expression of vimentin protein
in such cells as compared to the level of cell surface expression of
vimentin protein in a normal cell or a non-MDR neoplastic cell.